Evaluation of Conjugated VesiVax® Formulations for HIV Vaccines
Award Notice Posted
- Solicitation number
- PHS-2020-1
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Molecular Express, Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93020C00010 Federal contract award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- Not on record
Notice details come from SAM.gov. Updated .
About this opportunity
Molecular Express Inc. was awarded a contract by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to evaluate conjugated versions of the VesiVax vaccine to prevent HIV/AIDS under contract number 75N93020C00010 valued at $299,961 effective June 1, 2020. The contractor will support the NIH's research efforts toward developing effective HIV immunization strategies by evaluating conjugated VesiVax formulations for potential use in HIV vaccines over the ensuing period.
Notice text
Awarded contract 75N93020C00010 to MOLECULAR EXPRESS INC for 299961.00 on 2020-06-01.
Notice history
5 of 7 notices listed here. See the rest on GovTribe.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity